ANAPHORE

WIPO WIPO 2009

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke ANAPHORE wurde als Wortmarke am 29.05.2009 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 24. Februar 2023

Markenform Wortmarke
Aktenzeichen 1002978
Länder Australien China Europäische Gemeinschaft Japan Südkorea
Anmeldedatum 29. Mai 2009
Ablaufdatum 14. Januar 2013

Markeninhaber

Suite 101,
10931 North Torrey Pines Road
US

Markenvertreter

1299 Pennsylvania Avenue, NW, Suite 700 Washington DC 20004 US

Waren und Dienstleistungen

05 Pharmaceutical compositions and preparations for use in therapeutics for human, animal and livestock diseases, namely, use for cardiovascular disease, metabolic disease, autoimmune disease, diabetes, obesity, inflammatory disease, vascular disease, dermatological disease, ocular disease, hematological disease, neurological disease, gastrointestinal disease, respiratory disease, viral and infectious disease, cancer, allergies, allograft rejection, genetic disorders, diseases of the musculoskeletal and nervous system, analgesics and wound healing; pharmaceutical compositions and preparations for the diagnosis, prophylaxis and treatment of human, animal and livestock diseases, namely, cardiovascular disease, metabolic disease, autoimmune disease, diabetes, obesity, inflammatory disease, vascular disease, dermatological disease, ocular disease, hematological disease, neurological disease, gastrointestinal disease, respiratory disease, viral and infectious disease, cancer, allergies, allograft rejection, genetic disorders, diseases of the musculoskeletal and nervous system, analgesics and wound healing; vaccines; pharmaceutical compositions and preparations in the nature of contrast media for use with medical imaging equipment; biological reagents for use in clinical medical and non-clinical medical tests for the diagnosis and measurement of disease progression in human, animal and livestock diseases; biological reagents for use in clinical medical and non-clinical medical imaging; biological reagents for laboratory, clinical medical and non-clinical medical research applications
35 Advertising, marketing and promotional services for the biopharmaceutical industry
42 Pharmaceutical research and development services; biological research and development services; bacteriological research and development services; consulting services in the fields of biotechnology and pharmaceutical research, pertaining to therapeutics, research and development, laboratory testing and diagnostics
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
18. Dezember 2013 2014/10 Gaz US RAW: Total Ceasing Effect
09. August 2010 2010/32 Gaz KR Ablehnung
11. Mai 2010 2010/19 Gaz EM Ablehnung
14. Januar 2010 2010/2 Gaz JP Ablehnung
09. November 2009 2009/46 Gaz AU Ablehnung
29. Mai 2009 2009/24 Gaz US Eintragung

ID: 141002978